| Year |
Citation |
Score |
| 2022 |
Ingram J, Beasant L, Benson J, Brunt AM, Maxwell A, Harvey JR, Greenwood R, Roberts N, Williams N, Johnson D, Winters Z. The challenge of equipoise: qualitative interviews exploring the views of health professionals and women with multiple ipsilateral breast cancer on recruitment to a surgical randomised controlled feasibility trial. Pilot and Feasibility Studies. 8: 46. PMID 35227311 DOI: 10.1186/s40814-022-01007-1 |
0.421 |
|
| 2021 |
Rocco N, Catanuto G, Cinquini M, Audretsch W, Benson J, Criscitiello C, Di Micco R, Kovacs T, Kuerer H, Lozza L, Montagna G, Moschetti I, Nafissi N, O'Connell RL, Oliveri S, ... ... Winters Z, et al. Should oncoplastic breast conserving surgery be used for the treatment of early stage breast cancer? Using the GRADE approach for development of clinical recommendations. Breast (Edinburgh, Scotland). 57: 25-35. PMID 33711697 DOI: 10.1016/j.breast.2021.02.013 |
0.503 |
|
| 2018 |
Winters ZE, Bernaudo L. Evaluating the current evidence to support therapeutic mammoplasty or breast-conserving surgery as an alternative to mastectomy in the treatment of multifocal and multicentric breast cancers. Gland Surgery. 7: 525-535. PMID 30687626 DOI: 10.21037/gs.2018.07.01 |
0.565 |
|
| 2018 |
Winters ZE, Khajuria A. Quality of life after breast reconstruction-the BRIOS study. The Lancet. Oncology. 19: e579. PMID 30507482 DOI: 10.1016/S1470-2045(18)30709-5 |
0.321 |
|
| 2018 |
Winters ZE, Benson JR. Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report. Annals of Surgical Oncology. PMID 30414039 DOI: 10.1245/s10434-018-6982-8 |
0.58 |
|
| 2016 |
King MT, Winters ZE, Olivotto IA, Spillane AJ, Chua BH, Saunders C, Westenberg AH, Mann GB, Burnett P, Butow P, Rutherford C. Patient-reported outcomes in ductal carcinoma in situ: A systematic review. European Journal of Cancer (Oxford, England : 1990). 71: 95-108. PMID 27987454 DOI: 10.1016/j.ejca.2016.09.035 |
0.348 |
|
| 2010 |
McIntosh J, Dennison G, Holly JM, Jarrett C, Frankow A, Foulstone EJ, Winters ZE, Perks CM. IGFBP-3 can either inhibit or enhance EGF-mediated growth of breast epithelial cells dependent upon the presence of fibronectin. The Journal of Biological Chemistry. 285: 38788-800. PMID 20851879 DOI: 10.1074/jbc.M110.177311 |
0.453 |
|
| 2010 |
Winters ZE, Benson JR, Pusic AL. A systematic review of the clinical evidence to guide treatment recommendations in breast reconstruction based on patient- reported outcome measures and health-related quality of life. Annals of Surgery. 252: 929-42. PMID 20729711 DOI: 10.1097/SLA.0b013e3181e623db |
0.561 |
|
| 2009 |
Winters ZE. Immediate breast reconstruction should be challenged. Bmj (Clinical Research Ed.). 338: b1067. PMID 19293208 DOI: 10.1136/bmj.b1067 |
0.391 |
|
| 2008 |
Thomson HJ, Potter S, Greenwood RJ, Bahl A, Barker J, Cawthorn SJ, Winters ZE. A prospective longitudinal study of cosmetic outcome in immediate latissimus dorsi breast reconstruction and the influence of radiotherapy. Annals of Surgical Oncology. 15: 1081-91. PMID 18224376 DOI: 10.1245/s10434-007-9772-2 |
0.394 |
|
| 2006 |
McGurk R, Fallowfield L, Winters Z. Information provision for patients by breast cancer teams about the side-effects of hormone treatments. European Journal of Cancer (Oxford, England : 1990). 42: 1760-7. PMID 16790339 DOI: 10.1016/j.ejca.2006.03.014 |
0.535 |
|
| 2005 |
Clark MA, Perks CM, Winters ZE, Holly JM. DNA damage uncouples the mitogenic response to IGF-I in MCF-7 malignant breast cancer cells by switching the roles of PI3 kinase and p21WAF1/Cip1. International Journal of Cancer. 116: 506-13. PMID 15818613 DOI: 10.1002/ijc.21029 |
0.351 |
|
| 2004 |
Vestey SB, Perks CM, Sen C, Calder CJ, Holly JMP, Winters ZE. Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome. Breast Cancer Research. 7: 1-11. PMID 15642160 DOI: 10.1186/Bcr963 |
0.45 |
|
| 2002 |
Vestey S, Winters Z. Correspondence re: Geradts J, Wilentz RE, Roberts H. Immunohistochemical detection of the alternate ink4a-encoded tumor suppressor protein p14(arf) in archival human cancers and cell lines using commercial antibodies: correlation with p16(ink4a) expression. Mod pathol 2001;14:1162-68. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 15: 1106; author reply 1. PMID 12379759 DOI: 10.1038/modpathol.3880662 |
0.43 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2014 |
Turner EJ, Benson JR, Winters ZE. Techniques in the prevention and management of seromas after breast surgery. Future Oncology (London, England). 10: 1049-63. PMID 24941989 DOI: 10.2217/fon.13.257 |
0.255 |
|
| 2016 |
Bidad N, MacDonald L, Winters ZE, Edwards SJ, Emson M, Griffin CL, Bliss J, Horne R. How informed is declared altruism in clinical trials? A qualitative interview study of patient decision-making about the QUEST trials (Quality of Life after Mastectomy and Breast Reconstruction). Trials. 17: 431. PMID 27590594 DOI: 10.1186/S13063-016-1550-7 |
0.246 |
|
| 2018 |
Oberguggenberger AS, Nagele E, Inwald EC, Tomaszewski K, Lanceley A, Nordin A, Creutzberg CL, Kuljanic K, Kardamakis D, Schmalz C, Arraras J, Costantini A, Almont T, Wei-Chu C, Dehandschutter S, ... Winters Z, et al. Phase 1-3 of the cross-cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ-22. Cancer Medicine. PMID 29436144 DOI: 10.1002/Cam4.1338 |
0.148 |
|
| 2003 |
Winters ZE, Leek RD, Bradburn MJ, Norbury CJ, Harris AL. Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis. Breast Cancer Research : Bcr. 5: R242-9. PMID 14580260 DOI: 10.1186/Bcr654 |
0.088 |
|
| 2017 |
Mercieca-Bebber R, King MT, Boxer MM, Spillane A, Winters ZE, Butow PN, McPherson J, Rutherford C. What quality-of-life issues do women with ductal carcinoma in situ (DCIS) consider important when making treatment decisions? Breast Cancer (Tokyo, Japan). PMID 28247220 DOI: 10.1007/s12282-017-0765-0 |
0.078 |
|
| Hide low-probability matches. |